Free Trial

B. Riley Has Negative Outlook for TCMD Q3 Earnings

Tactile Systems Technology logo with Medical background

Key Points

  • B. Riley has downgraded its Q3 2025 earnings per share estimate for Tactile Systems Technology (TCMD) from $0.20 to $0.14 and maintains a "Neutral" rating with a price objective of $13.00.
  • The company reported earnings of $0.14 for the recent quarter, surpassing the consensus estimate of $0.09 and achieving revenue of $78.91 million, above the expected $73.93 million.
  • Shares of TCMD opened at $12.54 on Wednesday, reflecting a market cap of $291.56 million with an average target price of $13.50 from analysts.
  • Looking to export and analyze Tactile Systems Technology data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Tactile Systems Technology, Inc. (NASDAQ:TCMD - Free Report) - Stock analysts at B. Riley reduced their Q3 2025 earnings per share (EPS) estimates for Tactile Systems Technology in a report issued on Monday, August 4th. B. Riley analyst A. Schock now anticipates that the company will post earnings of $0.14 per share for the quarter, down from their prior forecast of $0.20. B. Riley currently has a "Neutral" rating and a $13.00 price objective on the stock. The consensus estimate for Tactile Systems Technology's current full-year earnings is $0.70 per share. B. Riley also issued estimates for Tactile Systems Technology's Q4 2025 earnings at $0.48 EPS, FY2025 earnings at $0.63 EPS and FY2026 earnings at $0.91 EPS.

Several other analysts have also recently commented on TCMD. Wall Street Zen upgraded shares of Tactile Systems Technology from a "hold" rating to a "buy" rating in a research report on Saturday. William Blair upgraded shares of Tactile Systems Technology to a "strong-buy" rating in a research report on Tuesday, August 5th. Finally, Piper Sandler cut shares of Tactile Systems Technology from an "overweight" rating to a "neutral" rating and lowered their price objective for the company from $25.00 to $14.00 in a research report on Tuesday, May 6th. Four research analysts have rated the stock with a hold rating, one has given a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $13.50.

Read Our Latest Stock Analysis on Tactile Systems Technology

Tactile Systems Technology Trading Down 1.3%

NASDAQ:TCMD traded down $0.16 during trading hours on Wednesday, hitting $12.28. 225,255 shares of the stock were exchanged, compared to its average volume of 250,764. The company's 50 day moving average is $10.26 and its two-hundred day moving average is $12.52. Tactile Systems Technology has a twelve month low of $8.61 and a twelve month high of $21.10. The company has a quick ratio of 3.99, a current ratio of 3.79 and a debt-to-equity ratio of 0.11. The company has a market capitalization of $273.75 million, a P/E ratio of 19.81 and a beta of 0.96.

Tactile Systems Technology (NASDAQ:TCMD - Get Free Report) last released its quarterly earnings data on Monday, August 4th. The company reported $0.14 earnings per share for the quarter, beating analysts' consensus estimates of $0.09 by $0.05. The company had revenue of $78.91 million for the quarter, compared to the consensus estimate of $73.93 million. Tactile Systems Technology had a return on equity of 7.72% and a net margin of 5.06%.

Insider Activity at Tactile Systems Technology

In related news, CFO Elaine M. Birkemeyer sold 2,921 shares of Tactile Systems Technology stock in a transaction on Monday, May 12th. The shares were sold at an average price of $9.94, for a total transaction of $29,034.74. Following the completion of the transaction, the chief financial officer owned 99,111 shares of the company's stock, valued at $985,163.34. This trade represents a 2.86% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 2.50% of the company's stock.

Institutional Investors Weigh In On Tactile Systems Technology

A number of institutional investors have recently added to or reduced their stakes in TCMD. Vanguard Group Inc. grew its position in shares of Tactile Systems Technology by 1.2% during the 1st quarter. Vanguard Group Inc. now owns 1,501,006 shares of the company's stock valued at $19,843,000 after acquiring an additional 17,314 shares during the period. Dimensional Fund Advisors LP boosted its holdings in Tactile Systems Technology by 8.1% in the 4th quarter. Dimensional Fund Advisors LP now owns 901,551 shares of the company's stock valued at $15,444,000 after purchasing an additional 67,934 shares during the period. Acadian Asset Management LLC boosted its holdings in Tactile Systems Technology by 248.3% in the 2nd quarter. Acadian Asset Management LLC now owns 683,662 shares of the company's stock valued at $6,930,000 after purchasing an additional 487,392 shares during the period. Deutsche Bank AG raised its position in shares of Tactile Systems Technology by 1.0% during the 1st quarter. Deutsche Bank AG now owns 623,033 shares of the company's stock valued at $8,236,000 after buying an additional 6,421 shares in the last quarter. Finally, Renaissance Technologies LLC raised its position in shares of Tactile Systems Technology by 44.0% during the 4th quarter. Renaissance Technologies LLC now owns 451,100 shares of the company's stock valued at $7,727,000 after buying an additional 137,900 shares in the last quarter. 83.43% of the stock is owned by institutional investors.

About Tactile Systems Technology

(Get Free Report)

Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.

Featured Articles

Earnings History and Estimates for Tactile Systems Technology (NASDAQ:TCMD)

Should You Invest $1,000 in Tactile Systems Technology Right Now?

Before you consider Tactile Systems Technology, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tactile Systems Technology wasn't on the list.

While Tactile Systems Technology currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything
Top Trades: Massive Gains and Costly Mistakes to Avoid
NVIDIA Earnings: All Signs Point to More Growth Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines